Acutus Medical (AFIB) Stock Price, News & Analysis

Company Overview

Acutus Medical is a commercial-stage medical technology company specializing in the development and commercialization of advanced cardiac mapping systems designed to improve the diagnosis and treatment of complex cardiac arrhythmias. The company’s flagship product, AcQMap, integrates high-resolution ultrasound imaging with electrical mapping to deliver comprehensive three-dimensional visualizations of arrhythmic sources, aiding electrophysiologists in the targeted management of conditions such as atrial fibrillation.

The AcQMap system employs a noncontact, high-density mapping catheter alongside ultrasound-based anatomical reconstruction to enable rapid, global mapping of cardiac chambers. By capturing electrical and anatomical data concurrently, the technology can reduce procedural times and enhance ablation precision compared with traditional point-by-point mapping approaches. Acutus Medical also provides clinical training, technical support and service programs to help health-care institutions incorporate its mapping solutions into routine electrophysiology workflows.

Founded in 2011 and headquartered in Carlsbad, California, Acutus Medical has secured regulatory clearances including FDA approval in the United States and CE marking in Europe. The company maintains a growing commercial presence across North America and key European markets, serving leading cardiac centers that manage complex arrhythmias. This global footprint reflects Acutus’s focus on expanding access to high-resolution diagnostic tools for atrial and ventricular mapping.

Under the leadership of President and Chief Executive Officer Robert E. White, Acutus Medical has transitioned from a development-stage enterprise to a public company with an emphasis on innovation. The firm continues to invest in research and development initiatives aimed at refining its mapping algorithms and broadening its electrophysiology portfolio, seeking to address a wider range of arrhythmic conditions and enhance overall patient outcomes.

Key Stats

• Today's Range: $0.0002 to $0.0002
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0140
• Volume: 8,085 shs
• Average Volume: 6,296 shs
• Market Capitalization: $5.98 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 11/11/2021
• Today: 6/04/2026
• Next Earnings (Estimated): 8/07/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:AFIB
• CIK: 1522860
• Web: www.acutusmedical.com
• Phone: 442-232-6080
• Fax: 442-232-6081
• Employees: 340
• Year Founded: 2011

Profitability

• EPS (Trailing Twelve Months): ($0.11)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$81.66 million
• Net Margins: -272.74%
• Pretax Margin: -30.32%
• Return on Equity: -311.64%
• Return on Assets: -11.57%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.85
• Quick Ratio: 1.57

Sales & Book Value

• Annual Sales: $7.16 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.03) per share
• Price / Book: -0.01

Miscellaneous

• Outstanding Shares: 29,912,000
• Free Float: 28,228,000
• Market Cap: $5.98 thousand
• Optionable: Optionable
• Beta: 5.69